Two epigenetic regulators interfere with healthy aging

- Posted by admin in English

It has long been assumed that lifespan and health are strongly correlated, but although there has been an overall increase in human life expectancy in recent decades, it is too often accompanied by deterioration of health.

A new study published on February 26 in Nature shows the influence of two epigenetic regulators on aging. Scientists led by Jie Yuan from the Chinese Academy of Sciences in Shanghai have studied the BAZ-2 and SET-6 proteins in Caenorhabditis elegans worms, which are orthologs of the human proteins BAZ2B and EHMT1.

Through genome-wide RNA-interference-based screening of genes that regulate behavioral deterioration in aging C. elegans, the researchers identified 59 genes as potential health modulators during aging. Essentially the proteins expressed by these genes, read and write epigenetic signals.

Among these modulators, they found that a neuronal epigenetic reader, BAZ-2, and a neuronal histone SET-6, accelerate the deterioration of the behavior of C. elegans by reducing the mitochondrial function, and repressing the expression of the encoded mitochondrial proteins. in the cell nucleus.

The researchers found that the levels of the two proteins increase with age in C. elegans and mice, which in turn attenuates the expression of genes involved in mitochondrial function.

BAZ-2 and SET-6 are complementary epigenetic mechanisms. SET-6 is an "epigenetic writer" and BAZ-2 is an "epigenetic reader" which recognizes modified histones and recruits transcriptional regulators.

Histones are proteins located in the nucleus of eukaryotic cells. They are the main protein components of chromosomes. They are closely associated with DNA and allow their compaction, but they also modify the expression of proteins by various epigenetic mechanisms known as the "histone code".

enter image description here Source Wikipedia.

How do BAZ-2 and SET-6 accelerate aging? The researchers found that the two proteins bind together to the promoter regions of more than 2,000 genes, and decrease their expression via methylation of histones. Among these target genes are many mitochondrial genes encoded nuclear. By suppressing the expression of these genes, BAZ-2 and SET-6 reduce oxygen consumption and ATP production, and decrease the critical stress responses that maintain mitochondrial proteostasis. The resulting metabolic slowdown discourages the worms from assimilating their food and they mate less.

This mechanism is conserved in the neurons of cultured mice and human cells. What about the orthologs of these epigenetic proteins in humans? A review of the databases shows that expression by human orthologs of the two proteins mentioned above, BAZ2B and EHMT1, increases with age and is positively correlated with the progression of Alzheimer's disease. Researchers have verified that ablation of BAZ-2 mouse ortholog Baz2b attenuates age-dependent body weight gain and prevents cognitive decline in aging mice.

enter image description here While wild-type mice grew fat with age, animals lacking both copies of the epigenetic reader Baz2b stayed trim, indicating improved mitochondrial function. [Yuan et al., Nature, 2020.]

However, it must be asked whether BAZ-2 and SET-6 would rather mediate age-related physiological adaptation, rather than the agents of aging itself. Indeed their action could reflect a mechanism of adaptation to a progressively more hostile biological environment.

The scientists here previously demonstrated the potential of utilizing non-cultured primary corneal endothelial cells isolated from donor corneas with low endothelial cell density for simple non-cultured endothelial cell injection therapy. This study aimed to develop a robust and semi-automated approach for cell counting, characterize the extent of cellular manipulation, and evaluate the translational workflow. To address this, the authors evaluated manual and automated cell counting approaches and characterized the extent of manipulation of CEnCs through the analysis of cell cycle status, gene expressions, and transcriptomic profiles with single-cell RNA-sequencing. Analysis of cell cycle status, cell cycle genes, and transcriptomic profiles revealed close resemblance between the native corneal endothelium and its donor-matched SNEC-I-harvested cells. In conclusion, SNEC-I therapy serves as an attractive corneal endothelial therapeutic approach in view of the minimal extent of cellular manipulation.

Read the original article on Pubmed

FRAXplus facilitates adjustment of FRAX fracture probabilities for additional clinical risk factors. This study examined how FRAXplus adjustments affect the proportion of older Swedish women eligible for treatment at a major osteoporotic fracture probability intervention threshold 26%.

Read the original article on Pubmed

Despite significant research efforts, effective therapies for brain rewiring and functional recovery after cerebral ischemia remain elusive. A deeper understanding of the cellular and molecular mechanisms involved in the post-acute phase of stroke may help identify novel therapeutic strategies for age-associated vascular pathologies. Recent advances have highlighted several promising areas, including epigenetic modifications of the vascular wall, blood-brain barrier remodeling, cell- and subcellular-based therapies, and innovative delivery methods.

Read the original article on Pubmed

This study aims to systematically analyze the disease burden of Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder in children aged 0-14 years, utilizing data from the Global Burden of Disease 2021 database. This study, based on GBD 2021 data, analyzed the incidence, prevalence, and disability-adjusted life years of ASD and Attention deficit hyperactivity disorder globally from 1990 to 2021. The research employed age-standardized rates to eliminate the influence of population age structure and explored the contributions of epidemiological changes, including population size, aging, as well as disease incidence, prevalence, mortality, and risk factors, to DALY through decomposition analysis. In 2021, the prevalence of ASD among the global population aged 0-14 years was 857.14 cases per 100,000 individuals, while the prevalence of Attention deficit hyperactivity disorder was 1,661.61 cases per 100,000 individuals. These two disorders exhibit differences in gender and age distribution, with higher incidence rates and DALY values observed in males. Projections indicate that from 2021 to 2050, the DALY for both ASD and Attention deficit hyperactivity disorder in the 0-14 age group are expected to show an upward trend.

Read the original article on Pubmed

Despite this, the connection between epigenetic information loss and disease has not been thoroughly investigated.

Read the original article on Pubmed


Please, help us continue to provide valuable information: